S1. Generation of PCDH7LSL mice and analysis of lung tumors in vivo. S2. TUNEL staining of lung tumors. S3. Validation of CRISPR/Cas9-editing of Pcdh7. S4. Diminished invasiveness in Pcdh7 depleted KP tumors. S5. Sequences of gene-edited alleles in KP tumors.